Tag - Recall

Provider Alert!
02Feb

Provider Alert! Class I Drug Recall Notification: Zenzedi

Date: February 1, 2024 Attention: Providers Effective date: Immediately Call to action: On January 24, 2024, Azurity Pharmaceuticals voluntarily recalled one (1) lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg due to mislabeled packaging. ProductNDC No.Lot No.Exp. DateShip Dates toWholesalersZenzedi®(dextroamphetaminesulfate tablets, USP)30 mg24338-856-03F230169A2025-0608/23/2023 –11/29/2023 How this impacts providers: Patients who received this medication within the ship dates of 8/23/23-11/29/23 are required to return the medication and receive a replacement.  Next step for Providers: Providers should inform their impacted patients and arrange for the...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , 0 CommentsRead more...
Provider Alert!
05Jan

Provider Alert! Nutramigen LGG Powdered Infant Formula Recall

Date: January 5, 2024 Attention: All Providers Effective: December 30, 2023 Call to action: Texas Children’s Health Plan (TCHP) received notice of an urgent recall from The Food and Drug Administration (FDA) for certain Nutramigen Hypoallergenic Infant Formula Powder products due to possible Cronobacter sakazakii contamination. The FDA is alerting parents, caregivers and health care providers not to use the recalled products. These recalled powdered infant formulas may be contaminated with Cronobacter sakazakii, a bacterium that can cause severe illness caused by food contamination. No illnesses have...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , 0 CommentsRead more...
Provider Alert!
22Feb

Provider Alert! Enfamil Prosobee Recall Information

Date: February 22, 2023  Attention: All Providers Call to action: Texas Children’s Health Plan (TCHP) received an urgent notice of Reckitt’s voluntary recall of two select batches of ProSobee plant-based infant formulas due to a possibility of cross-contamination with Cronobacter Sakazakii. TCHP wanted to ensure that our providers are aware of this important Member safety matter and are prepared to assist our Members in obtaining appropriate replacement formulas. Please inform Members DO NOT USE: Product: Enfamil ProSobee Powder, 12.9 oz Can Global Batch Code: ZL2HZF UPC: 300871214415 Lot...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , , 0 CommentsRead more...
Provider Alert!
06Sep

Provider Alert! Updated Notice: Kate Farms Pediatric Standard 1.2 Vanilla Formula Recall Expanded

Date: September 2, 2022 Attention: All Providers Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Texas Children’s Health Plan (TCHP) received an urgent notice of the voluntary recall of Kate Farms Pediatric Standard 1.2 Vanilla formula which has been expanded to include additional Kate...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
03Mar

Provider Alert! Abbott Recall of Certain Powdered Formulas: Similac, Alimentum, EleCare, Elecare Jr. and Similac PM 60/40

Date: March 2, 2022  Attention: All Providers Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Regarding system configuration updates, TCHP will apply updates and reprocess impacted claims as soon as possible. However, due to volume, please allow up to sixty (60) business days to complete. Providers...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , , 0 CommentsRead more...
Provider Alert!
24Sep

Provider Alert! Chantix (Varenicline) Tablets Voluntary Recall

Date: September 22, 2021 Attention: All Providers and Pharmacies Effective Date: September 16, 2021 Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Pfizer has issued a voluntary recall of all lots of CHANTIX (Varenicline) Tablets. Potentially impacted customers were notified with a recommendation to not stop...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , , 0 CommentsRead more...
Provider Alert!
01Jul

Provider Alert! Voluntary Recall Notice: Phillips Respironics Medical Devices

Date: June 29, 2021 Subject: Voluntary Recall Notice: Phillips Respironics Medical Devices Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Texas Children’s Health Plan (TCHP) would like to make providers aware of an important voluntary recall Philips Respironics has initiated for two of their ventilators...

By Primary Care Providers, Provider Alert, Specialists, , , , , , , 0 CommentsRead more...
06Jan

Zantac/ranitidine drug recalls due to NDMA impurity

Multiple drug manufacturers have issued voluntary drug recalls for several Zantac drug products and its generic, ranitidine. Ranitidine is a histamine-2 receptor antagonist used to treat heartburn and related conditions. Potentially impacted customers are being notified with a recommendation to stop taking the medication and to discuss alternative therapies with their provider. The recalls are due to discovery of an impurity (N-nitrosodimethylamine [NDMA]) in the finished product. NDMA is classified as a probable human carcinogen that may be found in certain...

By OB/GYNs, Primary Care Providers, Specialists, , , 0 CommentsRead more...